Searched over 200M research papers
10 papers analyzed
These studies suggest that cerebral ischaemia symptoms include dizziness, headaches, memory loss, light-headedness, syncope, neurological deficits, and cognitive decline.
20 papers analyzed
Cerebral ischaemia, a condition characterized by reduced blood flow to the brain, can manifest through a variety of symptoms depending on the severity and type of ischaemia. This article synthesizes findings from multiple studies to provide a comprehensive overview of the symptoms associated with cerebral ischaemia.
Non-acute cerebral ischaemia often presents with symptoms such as headaches, dizziness, and memory loss, particularly in the aging population. These symptoms are frequently linked to cerebral small vessel disease (CSVD) and can be indicative of underlying cognitive decline. The Non-Acute Symptomatic Cerebral Ischemia Registration study (NASCIR) aims to investigate these symptoms further, focusing on their association with cognitive decline and other clinical outcomes.
Primary orthostatic cerebral ischaemia is a less common but significant condition where patients experience dizziness, light-headedness, or syncope upon standing. This condition is not typically associated with a significant drop in systemic blood pressure but is linked to abnormalities in the cervical blood vessels supplying the brain. Carotid endarterectomy has been shown to relieve these symptoms by addressing the underlying vascular issues.
In severe cases, cerebral ischaemia can lead to coma. This is often associated with global cerebral ischaemia or cerebral infarction, where the blood flow reduction is extensive enough to cause significant brain damage. The management of such cases involves addressing the underlying causes, such as thrombosis or embolism, and may include interventions like anti-platelet therapy, anticoagulation, thrombolysis, and surgical decompression.
Delayed cerebral ischaemia (DCI) is a complication that can occur after a subarachnoid haemorrhage, affecting 20-30% of patients. DCI can lead to clinical deterioration due to various mechanisms, including large vessel vasospasm, neuroinflammation, and microthromboembolism. Diagnosing DCI requires a multimodal approach, combining clinical examination, cerebral ultrasonography, and neuroimaging.
Focal cerebral ischaemia can occur during hemiplegic migraine attacks, characterized by transient motor and sensory deficits followed by severe headaches. This condition is associated with instability in cerebrovascular tone, leading to fluctuating blood flow and subsequent ischaemia in specific brain regions.
Interestingly, cerebral ischaemia can also have peripheral effects, such as gastrointestinal dysfunction. Studies in mice have shown that focal cerebral ischaemia can lead to the loss of myenteric neurons and changes in the expression of vasoactive intestinal peptide in the ileum, indicating a link between central and enteric nervous system pathologies.
Cerebral ischaemia presents with a wide range of symptoms, from non-acute manifestations like headaches and memory loss to severe outcomes such as coma. Understanding these symptoms and their underlying mechanisms is crucial for effective diagnosis and treatment. Ongoing research continues to shed light on the complex pathophysiology of cerebral ischaemia, paving the way for improved therapeutic strategies.
Most relevant research papers on this topic